| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokines | 3 | 2024 | 96 | 1.660 |
Why?
|
| Fasting | 1 | 2024 | 56 | 0.850 |
Why?
|
| Neoplasms | 5 | 2022 | 1377 | 0.830 |
Why?
|
| Disease Progression | 4 | 2024 | 667 | 0.810 |
Why?
|
| Cell Cycle | 1 | 2024 | 346 | 0.760 |
Why?
|
| Butyrates | 3 | 2016 | 34 | 0.750 |
Why?
|
| Students | 2 | 2023 | 626 | 0.620 |
Why?
|
| Syndecan-4 | 1 | 2018 | 4 | 0.580 |
Why?
|
| Durapatite | 1 | 2018 | 18 | 0.580 |
Why?
|
| Copper | 3 | 2012 | 134 | 0.570 |
Why?
|
| Glutathione | 2 | 2012 | 171 | 0.550 |
Why?
|
| Apoptosis | 4 | 2024 | 1568 | 0.550 |
Why?
|
| U937 Cells | 6 | 2016 | 31 | 0.540 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.530 |
Why?
|
| Signal Transduction | 12 | 2024 | 2157 | 0.530 |
Why?
|
| Histones | 1 | 2018 | 197 | 0.520 |
Why?
|
| Tyrosine | 5 | 1999 | 120 | 0.500 |
Why?
|
| Leukemia | 2 | 2016 | 54 | 0.500 |
Why?
|
| Exosomes | 1 | 2018 | 126 | 0.500 |
Why?
|
| Gene Expression | 2 | 2016 | 701 | 0.480 |
Why?
|
| Obesity | 1 | 2024 | 1151 | 0.470 |
Why?
|
| Inflammation | 2 | 2024 | 758 | 0.470 |
Why?
|
| Humans | 35 | 2026 | 43102 | 0.460 |
Why?
|
| Colonic Neoplasms | 4 | 2020 | 223 | 0.460 |
Why?
|
| Genistein | 3 | 2005 | 45 | 0.450 |
Why?
|
| Tennessee | 3 | 2022 | 93 | 0.440 |
Why?
|
| Cell Line, Tumor | 8 | 2026 | 2676 | 0.430 |
Why?
|
| Universities | 3 | 2023 | 559 | 0.430 |
Why?
|
| Lipid Peroxides | 2 | 2005 | 19 | 0.430 |
Why?
|
| S-Phase Kinase-Associated Proteins | 2 | 2024 | 23 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2024 | 299 | 0.430 |
Why?
|
| Benzo(a)pyrene | 4 | 2020 | 128 | 0.420 |
Why?
|
| Quercetin | 2 | 2005 | 46 | 0.410 |
Why?
|
| Prostatic Neoplasms | 5 | 2024 | 1092 | 0.400 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1723 | 0.390 |
Why?
|
| Nanoparticles | 1 | 2018 | 460 | 0.380 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2024 | 12 | 0.380 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 51 | 0.370 |
Why?
|
| Nickel | 1 | 2012 | 23 | 0.370 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2012 | 116 | 0.370 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2016 | 137 | 0.360 |
Why?
|
| Lipid Peroxidation | 1 | 2012 | 140 | 0.360 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 1999 | 139 | 0.350 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 140 | 0.350 |
Why?
|
| Colonic Pouches | 1 | 2011 | 10 | 0.340 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2011 | 21 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2008 | 108 | 0.340 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 220 | 0.330 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 20 | 0.320 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 134 | 0.310 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 51 | 0.310 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 415 | 0.310 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2011 | 104 | 0.300 |
Why?
|
| Cytokines | 2 | 2015 | 678 | 0.300 |
Why?
|
| Interleukin-17 | 2 | 1999 | 53 | 0.300 |
Why?
|
| Health Services Research | 1 | 2010 | 161 | 0.300 |
Why?
|
| Cell Movement | 3 | 2024 | 655 | 0.290 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1997 | 41 | 0.280 |
Why?
|
| Interleukins | 1 | 2008 | 40 | 0.280 |
Why?
|
| Cell Proliferation | 6 | 2024 | 1455 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 105 | 0.270 |
Why?
|
| Schools, Medical | 1 | 2010 | 208 | 0.270 |
Why?
|
| Tumor Cells, Cultured | 7 | 2018 | 508 | 0.260 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1999 | 257 | 0.260 |
Why?
|
| Phosphotyrosine | 5 | 1999 | 23 | 0.250 |
Why?
|
| Animals | 12 | 2024 | 16992 | 0.240 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2026 | 23 | 0.240 |
Why?
|
| Fetal Hemoglobin | 3 | 2003 | 13 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1995 | 26 | 0.230 |
Why?
|
| Mice | 8 | 2024 | 6644 | 0.230 |
Why?
|
| Iron | 2 | 2005 | 251 | 0.220 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 512 | 0.220 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1596 | 0.220 |
Why?
|
| Enzyme Activation | 6 | 2008 | 462 | 0.220 |
Why?
|
| Mice, Obese | 1 | 2024 | 42 | 0.210 |
Why?
|
| Receptors, Chemokine | 1 | 2024 | 72 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 1999 | 10 | 0.210 |
Why?
|
| Flavonoids | 1 | 2005 | 100 | 0.210 |
Why?
|
| Linolenic Acids | 1 | 2003 | 1 | 0.210 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 144 | 0.210 |
Why?
|
| Neovascularization, Pathologic | 1 | 2024 | 139 | 0.200 |
Why?
|
| Autophagy | 1 | 2024 | 140 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2026 | 307 | 0.200 |
Why?
|
| Health Status Disparities | 1 | 2010 | 719 | 0.200 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2016 | 247 | 0.190 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 333 | 0.180 |
Why?
|
| Cell Line | 5 | 2016 | 1410 | 0.180 |
Why?
|
| NF-kappa B | 2 | 2016 | 358 | 0.180 |
Why?
|
| Saliva | 1 | 2023 | 119 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 12 | 0.180 |
Why?
|
| Repressor Proteins | 2 | 2024 | 273 | 0.180 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 23 | 0.180 |
Why?
|
| United States | 2 | 2022 | 5205 | 0.170 |
Why?
|
| Monocytes | 3 | 2008 | 277 | 0.170 |
Why?
|
| Hydroxyurea | 2 | 2003 | 34 | 0.160 |
Why?
|
| Atmospheric Pressure | 1 | 2020 | 11 | 0.160 |
Why?
|
| Research Personnel | 1 | 2022 | 206 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2022 | 166 | 0.160 |
Why?
|
| Pressure | 1 | 2020 | 50 | 0.160 |
Why?
|
| Phosphorylation | 6 | 1999 | 986 | 0.150 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 561 | 0.150 |
Why?
|
| Genes, jun | 2 | 1995 | 7 | 0.150 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 182 | 0.150 |
Why?
|
| Female | 5 | 2024 | 24698 | 0.150 |
Why?
|
| Thiobarbiturates | 2 | 2012 | 4 | 0.150 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 280 | 0.150 |
Why?
|
| Extracellular Space | 1 | 2018 | 36 | 0.140 |
Why?
|
| Ubiquitination | 2 | 2023 | 62 | 0.140 |
Why?
|
| Biotransformation | 1 | 2018 | 69 | 0.140 |
Why?
|
| Carcinogens | 2 | 2016 | 126 | 0.140 |
Why?
|
| Trans-Activators | 1 | 1999 | 192 | 0.140 |
Why?
|
| Antineoplastic Agents | 2 | 2026 | 1019 | 0.140 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 224 | 0.140 |
Why?
|
| Isoenzymes | 1 | 1998 | 168 | 0.140 |
Why?
|
| Endocytosis | 1 | 2018 | 118 | 0.140 |
Why?
|
| Hydrogen Peroxide | 2 | 2012 | 190 | 0.130 |
Why?
|
| Protein Kinase C | 1 | 1998 | 124 | 0.130 |
Why?
|
| RNA Interference | 1 | 2018 | 247 | 0.130 |
Why?
|
| Interleukin-15 | 1 | 1997 | 13 | 0.130 |
Why?
|
| Ligands | 1 | 2018 | 388 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 1997 | 49 | 0.130 |
Why?
|
| Liver | 1 | 2020 | 511 | 0.130 |
Why?
|
| Chemokine CCL20 | 1 | 2016 | 9 | 0.130 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 21 | 0.120 |
Why?
|
| HL-60 Cells | 1 | 2016 | 33 | 0.120 |
Why?
|
| Valproic Acid | 1 | 2016 | 21 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2018 | 403 | 0.120 |
Why?
|
| Chemokine CCL5 | 1 | 2016 | 41 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 968 | 0.120 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2015 | 8 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 105 | 0.120 |
Why?
|
| Cell Survival | 2 | 2016 | 945 | 0.120 |
Why?
|
| Genes, APC | 1 | 2015 | 15 | 0.120 |
Why?
|
| Interleukin-11 | 1 | 1995 | 3 | 0.120 |
Why?
|
| Erythroid Precursor Cells | 1 | 1995 | 5 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 1124 | 0.120 |
Why?
|
| Caspase 3 | 1 | 2016 | 227 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2021 | 518 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 1999 | 518 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1995 | 83 | 0.110 |
Why?
|
| Phosphoproteins | 2 | 1995 | 206 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2015 | 124 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 161 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 1995 | 20 | 0.110 |
Why?
|
| Antioxidants | 3 | 2018 | 443 | 0.110 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2005 | 13 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 526 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2015 | 144 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1271 | 0.110 |
Why?
|
| Kinetics | 4 | 1998 | 695 | 0.100 |
Why?
|
| Blotting, Western | 4 | 1999 | 883 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1993 | 14 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2005 | 457 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 39 | 0.090 |
Why?
|
| Edetic Acid | 1 | 2012 | 23 | 0.090 |
Why?
|
| Male | 8 | 2024 | 23409 | 0.090 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 2003 | 8 | 0.090 |
Why?
|
| Cell Division | 4 | 2003 | 311 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 384 | 0.080 |
Why?
|
| Cell Differentiation | 4 | 2015 | 638 | 0.080 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 70 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 165 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2010 | 83 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2010 | 121 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2010 | 89 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2015 | 1003 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2011 | 246 | 0.080 |
Why?
|
| Risk Factors | 2 | 2023 | 3994 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2023 | 1035 | 0.070 |
Why?
|
| Butadienes | 1 | 2008 | 29 | 0.070 |
Why?
|
| Nitriles | 1 | 2008 | 81 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 269 | 0.070 |
Why?
|
| Incidence | 1 | 2011 | 1078 | 0.070 |
Why?
|
| Butyric Acid | 2 | 1998 | 19 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 458 | 0.060 |
Why?
|
| Genes, fos | 2 | 1995 | 14 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2008 | 536 | 0.060 |
Why?
|
| Transfection | 2 | 2016 | 532 | 0.060 |
Why?
|
| K562 Cells | 2 | 2003 | 32 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2005 | 195 | 0.050 |
Why?
|
| Time Factors | 2 | 1999 | 1857 | 0.050 |
Why?
|
| Androgens | 1 | 2024 | 106 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 6 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 47 | 0.050 |
Why?
|
| Ferrous Compounds | 1 | 2003 | 22 | 0.050 |
Why?
|
| Monosaccharides | 1 | 2003 | 13 | 0.050 |
Why?
|
| Ions | 1 | 2003 | 71 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 347 | 0.050 |
Why?
|
| Urea | 1 | 2003 | 46 | 0.050 |
Why?
|
| Drug Stability | 1 | 2003 | 129 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 86 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2026 | 434 | 0.050 |
Why?
|
| alpha-Fetoproteins | 1 | 2022 | 32 | 0.050 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2021 | 12 | 0.040 |
Why?
|
| Benzamidines | 1 | 2000 | 5 | 0.040 |
Why?
|
| Hemoglobin, Sickle | 1 | 2000 | 11 | 0.040 |
Why?
|
| Porosity | 1 | 2020 | 43 | 0.040 |
Why?
|
| Streptozocin | 1 | 2000 | 26 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2000 | 33 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2020 | 169 | 0.040 |
Why?
|
| STAT2 Transcription Factor | 1 | 1999 | 1 | 0.040 |
Why?
|
| TYK2 Kinase | 1 | 1999 | 2 | 0.040 |
Why?
|
| STAT4 Transcription Factor | 1 | 1999 | 3 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 118 | 0.040 |
Why?
|
| Receptors, Interleukin-17 | 1 | 1999 | 9 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 1999 | 11 | 0.040 |
Why?
|
| Solvents | 1 | 2020 | 113 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 52 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 20 | 0.040 |
Why?
|
| Janus Kinase 3 | 1 | 1999 | 36 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 1999 | 36 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 1999 | 34 | 0.040 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1998 | 12 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 1999 | 102 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 52 | 0.040 |
Why?
|
| DNA Adducts | 1 | 2018 | 37 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 104 | 0.030 |
Why?
|
| Carcinogens, Environmental | 1 | 2018 | 35 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2018 | 52 | 0.030 |
Why?
|
| Prevalence | 1 | 2023 | 1612 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 2018 | 90 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 240 | 0.030 |
Why?
|
| Water | 1 | 2020 | 316 | 0.030 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1997 | 7 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 2016 | 5 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1997 | 91 | 0.030 |
Why?
|
| Chemokine CXCL1 | 1 | 2016 | 18 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 98 | 0.030 |
Why?
|
| Proteins | 1 | 1999 | 382 | 0.030 |
Why?
|
| Rats, Mutant Strains | 1 | 2016 | 7 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 148 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1996 | 219 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 1995 | 3 | 0.030 |
Why?
|
| Isoflavones | 1 | 1996 | 132 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 173 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 408 | 0.030 |
Why?
|
| Hydroquinones | 1 | 1995 | 10 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 197 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3156 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 259 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1993 | 13 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1993 | 18 | 0.030 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 1993 | 19 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1993 | 168 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1993 | 228 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 1070 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1993 | 1621 | 0.020 |
Why?
|
| Rats | 1 | 2016 | 3735 | 0.020 |
Why?
|
| Ribonucleotide Reductases | 1 | 2000 | 7 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2000 | 234 | 0.010 |
Why?
|